Kawakami K - Search Results

1

[Evaluation of the Leftover Capecitabine Tablets in Adjuvant CAPOX Chemotherapy for Gastric Cancer].

Kimura Y, Kawakami K, Nakamura M, Yokokawa T, Shimizu H, Kobayashi K, Aoyama T, Suzuki W, Hatori M, Suzuki K, Takahari D, Ogura M, Chin K, Nakayama I, Wakatsuki T, Yamaguchi K, Yamaguchi M. Kimura Y, et al. Among authors: kawakami k. Yakugaku Zasshi. 2023;143(12):1075-1081. doi: 10.1248/yakushi.23-00124. Yakugaku Zasshi. 2023. PMID: 38044112 Free article. Japanese.

2

[Drug information brochure for patients undergoing FOLFOX 4 chemotherapy based on survey of adverse reactions].

Imada H, Kawakami K, Hiraoka T, Higuchi S, Takahashi G, Aoyama T, Shinozaki E, Suenaga M, Matsuzaka S, Hama T. Imada H, et al. Among authors: kawakami k. Gan To Kagaku Ryoho. 2007 Sep;34(9):1425-30. Gan To Kagaku Ryoho. 2007. PMID: 17876140 Japanese.

3

[Preparation of a brochure for patients undergoing FOLFIRI chemotherapy based on survey of adverse reactions].

Kamisugi K, Matsusaka S, Imada H, Shoji D, Nakamoto E, Yokokawa T, Kawakami K, Hirata Y, Nawano K, Ogawa M, Shinozaki E, Suenaga M, Mizunuma N, Hatake K, Hama T. Kamisugi K, et al. Among authors: kawakami k. Gan To Kagaku Ryoho. 2008 Aug;35(8):1331-5. Gan To Kagaku Ryoho. 2008. PMID: 18701844 Japanese.

4

[Efficacy of preventive treatment for delayed emesis induced by FOLFOX4 chemotherapy].

Yokokawa T, Matsusaka S, Shouji D, Imada H, Nakamoto E, Kamisugi K, Suzuki W, Shirai T, Takahashi G, Kawakami K, Shinozaki E, Suenaga M, Mizunuma N, Hatake K, Hama T. Yokokawa T, et al. Among authors: kawakami k. Yakugaku Zasshi. 2009 Aug;129(8):949-55. doi: 10.1248/yakushi.129.949. Yakugaku Zasshi. 2009. PMID: 19652501 Free article. Japanese.

5

Patients' self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis.

Kawakami K, Nakamoto E, Yokokawa T, Sugita K, Mae Y, Hagino A, Suenaga M, Mizunuma N, Oniyama S, Machida Y, Yamaguchi T, Hama T. Kawakami K, et al. Patient Prefer Adherence. 2015 Apr 9;9:561-7. doi: 10.2147/PPA.S80327. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 25914526 Free PMC article.

6

Investigation of Regorafenib-induced Hypothyroidism in Patients with Metastatic Colorectal Cancer.

Sugita K, Kawakami K, Yokokawa T, Mae Y, Toya W, Hagino A, Suzuki K, Suenaga M, Mizunuma N, Yamaguchi T, Hama T. Sugita K, et al. Among authors: kawakami k. Anticancer Res. 2015 Jul;35(7):4059-62. Anticancer Res. 2015. PMID: 26124355

7

Risk Factors Exacerbating Hand-Foot Skin Reaction Induced by Capecitabine plus Oxaliplatin with or without Bevacizumab Therapy.

Yokokawa T, Kawakami K, Mae Y, Sugita K, Watanabe H, Suzuki K, Suenaga M, Mizunuma N, Yamaguchi T, Hama T. Yokokawa T, et al. Among authors: kawakami k. Ann Pharmacother. 2015 Oct;49(10):1120-4. doi: 10.1177/1060028015594451. Epub 2015 Jul 9. Ann Pharmacother. 2015. PMID: 26160973

8

Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study.

Sugita K, Kawakami K, Yokokawa T, Sugisaki T, Takiguchi T, Aoyama T, Suzuki K, Suenaga M, Yamaguchi K, Inoue A, Machida Y, Yamaguchi T, Hama T. Sugita K, et al. Among authors: kawakami k. Oncology. 2016;91(4):224-230. doi: 10.1159/000448717. Epub 2016 Aug 12. Oncology. 2016. PMID: 27513940

9

Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer.

Kawakami K, Yokokawa T, Kobayashi K, Sugisaki T, Suzuki K, Suenaga M, Yamaguchi K, Inoue A, Machida Y, Yamaguchi T, Hama T. Kawakami K, et al. Oncol Res. 2017 Nov 2;25(9):1625-1631. doi: 10.3727/096504017X15012905098071. Epub 2017 Aug 1. Oncol Res. 2017. PMID: 28766482 Free PMC article.

10

A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer -ACTOR Study.

Suenaga M, Akiyoshi T, Shinozaki E, Fujimoto Y, Matsusaka S, Konishi T, Nagayama S, Fukunaga Y, Kawakami K, Yokokawa T, Sugisaki T, Ueno M, Yamaguchi T. Suenaga M, et al. Among authors: kawakami k. Anticancer Res. 2018 Mar;38(3):1741-1747. doi: 10.21873/anticanres.12410. Anticancer Res. 2018. PMID: 29491111 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,628 results

Search Page